Literature DB >> 10389999

Seroconversion after influenza vaccination in patients with lung cancer.

H Anderson1, K Petrie, C Berrisford, A Charlett, N Thatcher, M Zambon.   

Abstract

There are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response rate is comparable to that obtained from healthy volunteers.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10389999      PMCID： PMC2362985          DOI： 10.1038/sj.bjc.6690342

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  5 in total

1.  Relation of chronic disease and immune response to influenza vaccine in the elderly.

Authors:  P A Gross; G V Quinnan; M E Weksler; U Setia; R G Douglas
Journal:  Vaccine       Date:  1989-08       Impact factor: 3.641

2.  Influenza among hospitalized adults with leukemia.

Authors:  H M Yousuf; J Englund; R Couch; K Rolston; M Luna; J Goodrich; V Lewis; N Q Mirza; M Andreeff; C Koller; L Elting; G P Bodey; E Whimbey
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

3.  Effectiveness of influenza vaccination policy at targeting patients at high risk of complications during winter 1994-5: cross sectional survey.

Authors:  J Watkins
Journal:  BMJ       Date:  1997-10-25

4.  Influenza immunization of adult patients with malignant diseases.

Authors:  D W Ortbals; H Liebhaber; C A Presant; A L Van Amburg; J Y Lee
Journal:  Ann Intern Med       Date:  1977-11       Impact factor: 25.391

5.  Antibody response to influenza immunization in adult patients with malignant disease.

Authors:  R A Shildt; D W Luedke; G Kasai; S El-Beheri; M N Laham
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860
  5 in total
  28 in total

1.  Efficacy of the influenza vaccine in patients with malignant lymphoma.

Authors:  Joseph J Mazza; Steven H Yale; Jodi R Arrowood; Cory E Reynolds; Ingrid Glurich; Po-Huang Chyou; James G Linneman; Kurt D Reed
Journal:  Clin Med Res       Date:  2005-11

2.  Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer.

Authors:  Yiqing Xu; Nanda Methuku; Praveena Coimbatore; Theresa Fitzgerald; Yiwu Huang; Ying-Yi Xiao; Murali Pagala; Shachi Gupta; William Solomon; Philip Rubin; John Treanor; Alan Astrow; Howard Minkoff; Jay S Cooper
Journal:  Oncologist       Date:  2012-01-12

3.  Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.

Authors:  Manpreet K Chadha; Marwan Fakih; Josephia Muindi; Lili Tian; Terry Mashtare; Candace S Johnson; Donald Trump
Journal:  Prostate       Date:  2010-09-01       Impact factor: 4.104

4.  Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.

Authors:  Roy E Strowd; Katrina Swett; Michele Harmon; Annette F Carter; Aurora Pop-Vicas; Michael Chan; Stephen B Tatter; Thomas Ellis; Maria Blevins; Kevin High; Glenn J Lesser
Journal:  Neuro Oncol       Date:  2014-04-08       Impact factor: 12.300

5.  Response to influenza immunisation during treatment for cancer.

Authors:  J C Chisholm; T Devine; A Charlett; C R Pinkerton; M Zambon
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

Review 6.  Practical review of immunizations in adult patients with cancer.

Authors:  Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Hum Vaccin Immunother       Date:  2015-06-25       Impact factor: 3.452

7.  Humoral and cellular immune responses to influenza vaccination in children with cancer receiving chemotherapy.

Authors:  Rosa María Wong-Chew; Margarita Nava Frías; Miguel Leonardo García-León; Lourdes Arriaga-Pizano; Aurora Medina Sanson; Constantino Lopez-Macías; Armando Isibasi; José Ignacio Santos-Preciado
Journal:  Oncol Lett       Date:  2012-05-17       Impact factor: 2.967

8.  Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy.

Authors:  Kei Nakashima; Masahiro Aoshima; Satoko Ohfuji; Kanzo Suzuki; Masahiro Katsurada; Naoko Katsurada; Masafumi Misawa; Yoshihito Otsuka; Kyoko Kondo; Yoshio Hirota
Journal:  Hum Vaccin Immunother       Date:  2016-11-07       Impact factor: 3.452

9.  Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae.

Authors:  Tone Nordøy; Ingeborg S Aaberge; Anne Husebekk; Helvi H Samdal; Svein Steinert; Hasse Melby; Arne Kolstad
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

10.  Immunogenicity of Influenza Vaccination in Patients With Cancer.

Authors:  Saiama N Waqar; Leigh Boehmer; Daniel Morgensztern; Andrea Wang-Gillam; Steven Sorscher; Steven Lawrence; Feng Gao; Kalin Guebert; Kristina Williams; Ramaswamy Govindan
Journal:  Am J Clin Oncol       Date:  2018-03       Impact factor: 2.339
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.